Impact of structure and formulation changes on the function of insulin products. [PDF]
Yang Y +4 more
europepmc +1 more source
Pulmonary mucormycosis with bacterial coinfection in an adolescent with poorly controlled type 1 diabetes: a case report. [PDF]
Rong F +6 more
europepmc +1 more source
Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes. [PDF]
Cunningham V +5 more
europepmc +1 more source
A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South Africa. [PDF]
Verryn MT, Cleary S.
europepmc +1 more source
Comparative efficacy and safety of antidiabetic agents in Alzheimer's disease: A network meta-analysis of randomized controlled trials. [PDF]
Cai Z, Zhong J, Zhu G, Zhang J.
europepmc +1 more source
Key Attributes of a Reusable Insulin Pen Injector That Balances Optimal Insulin Delivery With Sustainability. [PDF]
Wernersson AS +3 more
europepmc +1 more source
Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance [PDF]
David Owens
core +1 more source
Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trial. [PDF]
Juel CT +14 more
europepmc +1 more source
Correction to: Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study. [PDF]
Gölz S +4 more
europepmc +1 more source

